Literature DB >> 30860222

Effects of probiotic supplementation on the regulation of blood lipid levels in overweight or obese subjects: a meta-analysis.

Shoumeng Yan1, Zhenwei Tian, Meng Li, Bo Li, Weiwei Cui.   

Abstract

BACKGROUND: Obesity is a risk factor for many deadly diseases. Meanwhile, the prevalence of obesity has been continuously increasing in many countries. Probiotics are defined as live microorganisms that confer health benefits on hosts. Probiotic supplementation could reduce body weight, body mass index (BMI) and fat percentage. However, it is unclear whether supplementation with probiotics is beneficial to lower blood lipid levels for obese or overweight people.
METHODS: In this study, a comprehensive search across multiple databases was performed to identify studies that focused on the effects of probiotics on blood lipid levels in overweight or obese subjects. The meta-analysis included studies that compared the variations in blood lipid (total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL) and triglyceride (TG)) concentrations between overweight and obese subjects who were supplemented with probiotics versus the controls who were not supplemented with probiotics.
RESULTS: Our findings indicated that probiotic supplementation in obese or overweight people was associated with significantly larger reductions in TC and LDL levels compared to a lack of probiotic supplementation in the control subjects. However, there was no significant difference in the variations between HDL and TG concentrations.
CONCLUSION: Probiotic supplementation reduced TC and LDL concentrations in obese or overweight people. Additional data from large clinical trials are required to confirm the efficacy and safety of probiotics in the regulation of blood lipid levels in obese or overweight people.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30860222     DOI: 10.1039/c8fo02163e

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  5 in total

1.  Chitosan alleviated menopausal symptoms and modulated the gut microbiota in estrogen-deficient rats.

Authors:  Xuangao Wu; Min Jung Kim; Hye Jeong Yang; Sunmin Park
Journal:  Eur J Nutr       Date:  2020-09-10       Impact factor: 5.614

Review 2.  Targeted Delivery of Probiotics: Perspectives on Research and Commercialization.

Authors:  K S Yoha; Sundus Nida; Sayantani Dutta; J A Moses; C Anandharamakrishnan
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04-27       Impact factor: 5.265

3.  Preventive Effect and Molecular Mechanism of Lactobacillus rhamnosus JL1 on Food-Borne Obesity in Mice.

Authors:  Mo Yang; Jiapeng Zheng; Xinran Zong; Xinyan Yang; Yu Zhang; Chaoxin Man; Yujun Jiang
Journal:  Nutrients       Date:  2021-11-09       Impact factor: 5.717

4.  Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.

Authors:  Lei Chen; Liangyu Zhang; Wendong Wang; Wei Qiu; Lei Liu; Anhong Ning; Jing Cao; Min Huang; Mintao Zhong
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

5.  A randomised controlled trial of a probiotic and a prebiotic examining metabolic and mental health outcomes in adults with pre-diabetes.

Authors:  Christine Barthow; Fiona Hood; Julian Crane; Mark Huthwaite; Mark Weatherall; Amber Parry-Strong; Jeremy Krebs
Journal:  BMJ Open       Date:  2022-03-24       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.